Identification of a novel intra-genotype reassortant G1P[8] rotavirus in Italy, 2021.
G1P[8]
Italy
phylogenetic analyses
rotavirus
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
31 Jan 2024
31 Jan 2024
Historique:
received:
16
10
2023
revised:
26
01
2024
accepted:
26
01
2024
medline:
3
2
2024
pubmed:
3
2
2024
entrez:
2
2
2024
Statut:
aheadofprint
Résumé
Rotaviruses G1P[8] are epidemiologically relevant and are targeted by vaccines. The introduction of vaccines has altered rotavirus epidemiology. Hospital-based surveillance conducted in Sicily, Italy, showed a progressive decline in rotavirus prevalence since 2014, along with an increasing vaccine coverage (63.8% in 2020), and a marked decrease in circulation of G1P[8] strains. Surprisingly in 2021, G1P[8] viruses accounted for 90.5% (19/21) of rotavirus infections. This study aimed to understand if the increased activity of G1P[8]s was related to virus-related peculiarities. In 2021, 266 patients <15 years of age were hospitalized with acute gastro-enteritis (AGE) and included in rotavirus surveillance. VP7/VP4 genotyping and sequence data were generated from all rotavirus-positive samples. The genetic make- up of G1P[8] rotaviruses was investigated by full-genome sequencing. Peculiar G1P[8] rotaviruses, with VP7 and VP4 belonging to novel sub-lineages, circulated in 2021, accounting for 76.2% (16/21) of all rotavirus infections. On full-genome analysis, the novel G1P[8] variant displayed an intra-genotype (Wa-like) reassortant constellation, involving G12 and G1 strains, into a unique arrangement never observed before. The novel G1P[8] variant showed peculiar aa substitutions in 8-1 and 8-3 epitopes of the VP4 with respect to the Rotarix strain. Prompt identification of virus variants circulating in human population is pivotal to understanding epidemiological trends and assessing vaccine efficacy.
Identifiants
pubmed: 38307378
pii: S1201-9712(24)00020-1
doi: 10.1016/j.ijid.2024.01.020
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.